Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bauersachs

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Critical Reviews in Oncology/Hematology|November 30, 2020
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical managementHanno Riess, Peter Verhamme, Jeffrey I Weitz, et al.
Thrombosis and Haemostasis|December 8, 2009
Diagnosis of deep-vein thrombosis: adherence to guidelines and outcomes in real-world health careSebastian M Schellong, Horst Gerlach, Viola Hach-Wunderle, et al.
The Lancet. Haematology|February 22, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 9, 2016
Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Birgit Linnemann, Rupert Bauersachs, Hannelore Rott, et al.
Thrombosis Research|December 9, 2014
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trialMartin H Prins, Luke Bamber, Stefan J Cano, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2017
Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosisRupert Bauersachs, Horst Eberhard Gerlach, Andreas Heinken, et al.
JACC. Cardiovascular Interventions|April 7, 2021
The Role for Combined Antithrombotic Therapy With Platelet and Coagulation Inhibition After Lower Extremity RevascularizationE Hope Weissler, Victor Aboyans, Rupert Bauersachs, et al.
Cardiovascular Therapeutics|July 23, 2020
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled TrialsRupert Bauersachs, Olivia Wu, Jean-Baptiste Briere, et al.
Thrombosis and Haemostasis|July 13, 2013
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosisLuke Bamber, Maria Y Wang, Martin H Prins, et al.
The Lancet. Haematology|June 7, 2017
Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' replyJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|November 30, 2020
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical managementHanno Riess, Peter Verhamme, Jeffrey I Weitz, et al.
Thrombosis and Haemostasis|December 8, 2009
Diagnosis of deep-vein thrombosis: adherence to guidelines and outcomes in real-world health careSebastian M Schellong, Horst Gerlach, Viola Hach-Wunderle, et al.
The Lancet. Haematology|February 22, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 9, 2016
Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Birgit Linnemann, Rupert Bauersachs, Hannelore Rott, et al.
Thrombosis Research|December 9, 2014
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trialMartin H Prins, Luke Bamber, Stefan J Cano, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2017
Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosisRupert Bauersachs, Horst Eberhard Gerlach, Andreas Heinken, et al.
JACC. Cardiovascular Interventions|April 7, 2021
The Role for Combined Antithrombotic Therapy With Platelet and Coagulation Inhibition After Lower Extremity RevascularizationE Hope Weissler, Victor Aboyans, Rupert Bauersachs, et al.
Cardiovascular Therapeutics|July 23, 2020
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled TrialsRupert Bauersachs, Olivia Wu, Jean-Baptiste Briere, et al.
Thrombosis and Haemostasis|July 13, 2013
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosisLuke Bamber, Maria Y Wang, Martin H Prins, et al.
The Lancet. Haematology|June 7, 2017
Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' replyJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Pageof 14